> The other major disadvantage is that these drugs can interact with protease inhibitors
What are the possible consequences of this?
What are the possible consequences of this?
Kaletra, a protease inhibitor, is a combination of two drugs, one of which is a CYP3A4 inhibitor. It is used with some success on coronavirus patients.
Co-administering this with chloroquine 500mg/BID could easily result in chloroquine concentrations well above LD50.